5-Thioglucose—derived inhibitor 290, which has a sulfur atom in place of the oxygen atom in the glucose ring, is known as luseogliflozin and it is an orally active SGLT2 inhibitor for the treatment of patients with type 2 diabetes mellitus. Here, SLC5A2 is linked to type 2 diabetes mellitus.